Report: Drugs in Farm Feed, Despite Risk

A new analysis of government studies on animal feed uncovers widespread use of antibiotics, some of which pose risks to human health.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, BOB NICHOLS, USDA NATURAL RESOURCES CONSERVATION SERVICEOf 30 antibiotics added to animal feed, 18 pose risks to humans by potentially exposing people to antibiotic-resistant bacteria in foods. That’s the conclusion of research conducted by the U.S. Food and Drug Administration (FDA), recently analyzed by the Natural Resources Defense Council (NRDC). The FDA “is an agency that has repeatedly found, since the 1970s, that these drugs pose a risk to human health, but it has not done anything meaningful with those conclusions,” Avinash Kar, a lawyer for NRDC, told The New York Times.

By requests through the Freedom of Information Act, the NRDC obtained documents of FDA reviews of antibiotics in animal feed dated 2001 to 2010. According to a press release from the NRDC: “None of the 30 antibiotics would likely be approved as new additives for livestock use if submitted under current FDA guidelines, because drug makers have not submitted sufficient information to establish their safety.”

The Washington Post reported that the FDA has been planning to withdraw approval for some animal antibiotics since 1977. “But for decades, the agency took no action, even as the NRDC sued in recent years, trying to force it to follow through.”

Last year, the FDA asked pharmaceutical companies to voluntarily change the indications for their antibiotic products so that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies